Liver enzymes help break down food and turn it into energy and nutritional elements, among other things. Elevated levels ...

Autoimmune hepatitis (AIH) is a chronic, progressive liver disease caused by immune system dysregulation that targets the liver. If untreated, AIH can lead to severe complications, including cirrhosis ...

Autoimmune hepatitis quietly damages the liver for years before symptoms appear; specialists in Kenya warn of late diagnoses and urge early medical checks. [File, Standard] When people think about ...

Autoimmune hepatitis (AIH) is a complex, chronic inflammatory liver disorder in which the body's immune system aberrantly targets hepatocytes, leading to progressive hepatic injury. Characterised by ...

In response, the British Liver Trust has launched No One Left Behind, a new campaign aimed at shining a spotlight on rarer liver conditions that are too often under-recognised and misunderstood.

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In this video, Paul Kwo, MD, professor of medicine at Stanford University, discusses a plenary ...

The principle of therapy for chronic inflammatory liver diseases is the removal of causal agents. For autoimmune liver diseases, however, total removal of causal agents and immune cells is impossible.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In this video, Nancy S. Reau, MD, FAASLD, AGAF, speaks with Healio about findings from a systemic ...

AIH type 3 is serologically defined by the presence of SLA/LP autoantibodies. However, 74% of patients also have other serological markers of autoimmunity, including SMA and AMA. AIH type 3 has a ...

A major retrospective study shows that people with blood group A face a higher likelihood of autoimmune liver disease, especially primary biliary cholangitis, while those with blood group B appear ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...